Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-08

FDA Approved: FUROSEMIDE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for furosemide by Eugia US LLC under an ANDA, confirming approval of the supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)